ResearchPeptide

Ipamorelin

Published Research

PubMed-indexed studies for Ipamorelin

Research

Ipamorelin, the first selective growth hormone secretagogue.

European journal of endocrinology 1998

View on PubMed →

Research

Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.

Pharmaceutical research 1999

View on PubMed →

Research

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 1999

View on PubMed →

Research

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews 2026

View on PubMed →

Research

The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.

Physiology & behavior 2024

View on PubMed →

Research

Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.

Xenobiotica; the fate of foreign compounds in biological systems 1998

View on PubMed →

Research-Grade Ipamorelin

⚠️ For laboratory research only. Not for human use.

Ipamorelin

Published Research

Ipamorelin, the first selective growth hormone secretagogue.

Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.

Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.

Research-Grade Ipamorelin

Frequently Asked Questions

What are research peptides?

What does peptide purity mean and why does it matter?

What form do your peptides come in?

How should research peptides be stored?

Who can purchase research peptides?

How do you ensure peptide quality?

What does "Research Use Only" mean?

How are peptides shipped?

What is your return and refund policy?

Published Research

Ipamorelin, the first selective growth hormone secretagogue.

Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers.

Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats.

Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.

Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption.

Research-Grade Ipamorelin

Frequently Asked Questions

What are research peptides?

What does peptide purity mean and why does it matter?

What form do your peptides come in?

How should research peptides be stored?

Who can purchase research peptides?

How do you ensure peptide quality?

What does "Research Use Only" mean?

How are peptides shipped?

What is your return and refund policy?

⚠️ Research Use Only — Legal Acknowledgment